Quality of life · adolescents with asthma
1 finding from 1 review
Number experiencing adverse effects · the management of chronic obstructive pulmonary disease
It is very uncertain whether multi‐component intervention changes adverse events: number of people experiencing an AE compared with other intervention or routine, usual care or control treatment (very low certainty).
1 finding from 1 review
Number of participants experiencing any serious adverse events · the management of chronic obstructive pulmonary disease
Multi‐component intervention showed no clear difference in adverse events: number of people experiencing a serious adverse event compared with other intervention or routine, usual care or control treatment (low certainty).
1 finding from 1 review
Impact on health behaviour: 6MWD · the management of chronic obstructive pulmonary disease
1 finding from 1 review
Quality of life St George's Respiratory Questionnaire (SGRQ) score · the management of chronic obstructive pulmonary disease
1 finding from 1 review
Exacerbations (number of people experiencing ≥ 1 exacerbations) · the management of chronic obstructive pulmonary disease
It is very uncertain whether multi‐component intervention changes exacerbations: number of people experiencing at least one exacerbation compared with other intervention or routine, usual care or control treatment (very low certainty).
1 finding from 1 review
Exacerbations · people with asthma
Tailored interventions based on sputum eosinophils probably leads to lower number of participants who had one or more exacerbations over the… compared with tailored interventions based on clinical symptoms (moderate certainty).
1 finding from 1 review
Hospital admissions · people with asthma
Tailored interventions based on sputum eosinophils probably leads to lower hospitalisations compared with tailored interventions based on clinical symptoms (moderate certainty).
1 finding from 1 review
Mean dose of inhaled corticosteroids per person per day (BUD equivalent mcg/day) · people with asthma
1 finding from 1 review
Mean daily use of oral corticosteroids per person per day · people with asthma
1 finding from 1 review
Cost of treatment per person at 1 year · people with asthma
1 finding from 1 review
Prolonged abstinence at longest · smokers with COPD
1 finding from 1 review
Point prevalence abstinence at longest · smokers with COPD
1 finding from 1 review
Exacerbations: number of people experiencing moderate or severe exacerbations · treatment for asthma in adults and children with asthma and GORD
Medical or surgical intervention, or both, for gastro‐oesophageal… showed no clear difference in number of participants with moderate/severe acute exacerbations… compared with nil intervention, delayed intervention control, or placebo (low certainty).
1 finding from 1 review
Lung function: FEV1 mL (change from baseline) · treatment for asthma in adults and children with asthma and GORD
1 finding from 1 review
Use of "rescue" medications and emergency action plans: B2 use puffs per day Duration of treatment: range 14 weeks to 24 weeks · treatment for asthma in adults and children with asthma and GORD
1 finding from 1 review
Change in quality of life · treatment for asthma in adults and children with asthma and GORD
1 finding from 1 review
Healthcare utilisation ‐ not measured · treatment for asthma in adults and children with asthma and GORD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Daytime sleepiness (ESS): change from baseline. · adults with obstructive sleep apnoea
1 finding from 1 review
QoL · adults with obstructive sleep apnoea
1 finding from 1 review